Variational AI will participate in Drug Discovery Chemistry 2026, a premier conference for scientists focused on the discovery and optimization of small-molecule therapeutics.
The event brings together medicinal, biophysical, and computational chemists from pharmaceutical companies, biotechnology organizations, and academic institutions to discuss new strategies and technologies for advancing drug discovery.
Meet with Variational AI
Brian Atwood, Scientific Project Manager at Variational AI will be attending Drug Discovery Chemistry 2026 to connect with researchers and industry partners working at the intersection of AI, medicinal chemistry, and drug discovery.
If you are attending the conference and would like to learn more about Variational AI’s approach to generative molecular design, we would be happy to connect.
Tackling the Challenges of Modern Drug Discovery
Drug Discovery Chemistry focuses on the scientific challenges involved in discovering and optimizing small-molecule and macrocyclic drug candidates, with presentations spanning topics such as:
- medicinal chemistry strategies
- fragment-based drug discovery
- targeted protein degradation
- AI and machine learning in early drug discovery
- emerging approaches to difficult drug targets
The conference features hundreds of scientific presentations, poster sessions, and industry discussions, providing a venue for researchers to exchange ideas and explore the latest innovations shaping discovery chemistry.